专题:Cardiomyopathy and Myosin Studies

This cluster of papers focuses on the diagnosis, management, genetic basis, and clinical outcomes of hypertrophic cardiomyopathy. It explores topics such as cardiomyopathies, myosin mutations, left ventricular non-compaction, sudden death risk, cardiac imaging, titin mutations, dilated cardiomyopathy, and cardiac fibrosis.
最新文献
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study

article Full Text OpenAlex

Beta-Blocker (Bisoprolol) vs Calcium-Channel Blocker (Verapamil) in Nonobstructive Hypertrophic Cardiomyopathy

article Full Text OpenAlex

MYH9 mutations differentially stabilize non-muscle myosin II filaments and induce distinct cellular aggregation phenotypes

article Full Text OpenAlex

Refining comparative efficacy: Methodologic considerations for transapical beating-heart myectomy in pediatric hypertrophic cardiomyopathy

article Full Text OpenAlex

Cardiomyopathy Gene Variants and Polygenic Risk Scores in Atrial Fibrillation

article Full Text OpenAlex

Dynamic balance of myoplasmic energetics, redox state and protons in a fast‐twitch oxidative glycolytic skeletal muscle fibre

article Full Text OpenAlex

Mending the Achilles heels of titin in cardiac and musculoskeletal disease

article Full Text OpenAlex

Left bundle cardiac resynchronization therapy versus left bundle optimized cardiac resynchronization therapy

article Full Text OpenAlex

Spatial relationships between vinculin tension and actin at cell adhesions define cell colony positioning and identity

article Full Text OpenAlex

Integrating ECG Into the Mayo Score Enhances Genotype Prediction in Hypertrophic Cardiomyopathy

article Full Text OpenAlex

近5年高被引文献
2023 ESC Guidelines for the management of cardiomyopathies

article Full Text OpenAlex 2084 FWCI463.9033

Diagnosis and Evaluation of Hypertrophic Cardiomyopathy

review Full Text OpenAlex 531 FWCI81.7571

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

article Full Text OpenAlex 514 FWCI212.6768

2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure

article Full Text OpenAlex 432 FWCI95.9997

Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy

article Full Text OpenAlex 363 FWCI56.8031

Management of Hypertrophic Cardiomyopathy

review Full Text OpenAlex 359 FWCI54.9972

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases

article Full Text OpenAlex 334 FWCI52.8662

Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy

article Full Text OpenAlex 323 FWCI49.7438

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy

article Full Text OpenAlex 268 FWCI111.1826

Karyopherin-mediated nucleocytoplasmic transport

article Full Text OpenAlex 259 FWCI21.6203